Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death

Jonas J Neher1, Urte Neniskyte, Jing-Wei Zhao

  • 1Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom. jjn24@cam.ac.uk

Insights

Inflammation can cause microglia to engulf and kill healthy neurons by exposing "eat-me" signals. Blocking this phagocytic pathway rescues neurons, suggesting a new target for treating neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology

Background:

  • Microglia, the brain's immune cells, typically clear dead neurons via phagocytosis.
  • Neuronal loss in brain inflammation was assumed to result from phagocytosis of already dead neurons.

Purpose of the Study:

  • To investigate the role of phagocytosis in neuronal death during inflammation.
  • To identify mechanisms by which inflammation induces neuronal death and explore potential therapeutic targets.

Main Methods:

  • Primary rat cultures of neurons and glia were exposed to inflammatory bacterial ligands (lipoteichoic acid and LPS).
  • Microglial activity, neuronal engulfment, and the "eat-me" signal phosphatidylserine (PS) exposure were monitored.
  • Pharmacological inhibition of the phagocytic pathway (PS exposure, MFG-E8, vitronectin receptor) was employed.

Main Results:

  • Inflammatory stimuli (LPS, lipoteichoic acid) activated microglia, leading to the engulfment of approximately 30% of viable neurons within 3 days.
  • Neuronal phagocytosis was dependent on microglial release of soluble mediators, particularly peroxynitrite, which induced PS exposure on neurons.
  • Blocking the phagocytic pathway, including PS signaling, rescued up to 90% of neurons without reducing overall inflammation.

Conclusions:

  • Phagocytosis actively induces neuronal death under inflammatory conditions, representing a novel mechanism of inflammatory neurodegeneration.
  • Inflammation can trigger "eat-me" signals on viable neurons, leading to their phagocytic clearance.
  • Inhibiting microglial phagocytosis offers a potential therapeutic strategy for neurodegenerative conditions associated with inflammation.